Consensus IMAX Corporation

Stocks

IMAX

CA45245E1097

Entertainment Production

Market Closed - NYSE Other stock markets 06:00:02 28/07/26 am AEST			5-day change	1st Jan Change
45.11 ^USD	+3.99%		+14.93%	+22.05%

27/07	AMC, IMAX Report Strong 'Odyssey' Ticket Sales in Second Weekend	MT
25/07	IMAX Q2 Results Reinforce Long-Term Growth Outlook, Wedbush Says	MT

Evolution of the Average Target: IMAX Corporation

Evolution of the Target Price: IMAX Corporation

Changes in Analyst Recommendations: IMAX Corporation

75481e845945b08da265daf97ec.GmKXeuKEtoc2-tBJdQtYYp5Wp4azRVLaOf7ZgslzvVY.WDj4OKmx7M9hz6UvEVgKWqk_ku7jHCaNfpSpr_9B0w8uD9QUkf7zyA-A6A~4b94c900f7aee394a873c7d5e448d0ee

Analysts' recommendations: IMAX Corporation

25/07	IMAX Q2 Results Reinforce Long-Term Growth Outlook, Wedbush Says	MT
25/07	Barrington Research Adjusts IMAX Price Target to $50 From $46, Maintains Outperform Rating	MT
24/07	B. Riley Adjusts Price Target on IMAX to $52 From $48, Maintains Buy Rating	MT
24/07	Wedbush Adjusts Price Target on IMAX to $54 From $46, Maintains Outperform Rating	MT
17/07	IMAX's H2 Outlook Remains Strong Despite Modest Q2 Growth, Wedbush Says	MT
16/07	Wells Fargo Downgrades IMAX to Equalweight From Overweight, Cuts Price Target to $41 From $47	MT
10/07	B. Riley Adjusts IMAX Price Target to $48 From $46, Maintains Buy Rating	MT
19/05	IMAX on Track to Reach $1.4 Billion in Box Office Proceeds Despite Headwinds, B. Riley Says	MT
04/05	Barrington Raises Price Target on IMAX to $46 From $42, Keeps Outperform Rating	MT
02/05	IMAX is Poised to Surpass 50% EBITDA Margins by 2028 on Rise in Filmed-for-IMAX Titles, Wedbush Says	MT
24/04	IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says	MT
18/04	B. Riley Upgrades 2026 Box Office Outlook Following First-Quarter Beat	MT
27/02	Macquarie Raises Price Target on IMAX to $45 From $44, Keeps Outperform Rating	MT
27/02	IMAX Poised to Benefit from Multiple Factors, Wedbush Says	MT
27/02	B. Riley Adjusts Price Target on IMAX to $46 From $44, Maintains Buy Rating	MT
16/12	JPMorgan Upgrades IMAX to Overweight From Neutral, Adjusts Price Target to $47 From $32	MT
09/12	IMAX EBITDA Margins Seen Surpassing 50% by 2028, Wedbush Says	MT
09/12	Wedbush Raises Price Target on IMAX to $46 From $39, Keeps Outperform Rating	MT
09/12	Barrington Raises Price Target on IMAX to $42 From $37, Keeps Outperform Rating	MT
09/12	B. Riley Raises Price Target on IMAX to $44 From $40, Keeps Buy Rating	MT
25/11	Goldman Sachs Upgrades IMAX to Neutral From Sell, Adjusts Price Target to $34 From $22	MT
25/10/25	IMAX Reports 'Superb' Q3 Results, Wedbush Says	MT
21/10/25	US Box Office Set to Rebound in Fourth Quarter, B. Riley Says	MT
23/09/25	Imax Likely to Surpass 'Peak' EBITDA Margins in Two Years, Wedbush Says	MT
22/09/25	Wedbush Raises Price Target on IMAX to $39 From $35, Keeps Outperform Rating	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Objective/dr gap
IMAX CORPORATION		+15.89%
WARNER MUSIC GROUP CORP.		+42.68%
TKO GROUP HOLDINGS, INC.		+28.77%
BOLLORÉ SE		+16.79%
TOEI ANIMATION CO.,LTD.		+18.7%
SEGA SAMMY HOLDINGS INC.		+17.98%
TOEI COMPANY, LTD.	-	-4.07%
VIVENDI SE		+33.29%
Average		+21.25%
Weighted average by Cap.		+26.50%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

45.11USD

Average target price

50.27USD

Spread / Average Target

+11.44%

High Price Target

60.00USD

Spread / Highest target

+33.01%

Low Price Target

42.00USD

Spread / Lowest Target

-6.89%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Barrington Research
Wedbush
B. Riley
Wells Fargo Securities
Macquarie
JPMorgan Chase
Goldman Sachs
Buckingham Research
Rosenblatt Securities
Benchmark Company
Roth MKM
Morningstar
Truist Securities
Benchmark Capital
MKM Partners
Colliers Securities